Our Mission: Turning fundamental discoveries in stem cell science into therapies for today’s patients.

Stem cell biology and regenerative medicine promise unprecedented breakthroughs in healing for the 21st century. Among the world’s premier biomedical research institutions, the University of Washington School of Medicine and its affiliated institutions, Fred Hutch and Seattle Children’s, are leading-edge pioneers in this science.

The University of Washington Institute for Stem Cell and Regenerative Medicine plays an integral part in this network, developing the human body’s astonishing power to heal itself.

Seattle: Historic Hub for Technology and Biotech

There is no place on earth better suited to leading this effort than Seattle, Washington. The combination of our unmatched talent pool, a Northwest culture rooted in collaboration, and a deep sense of public mission led by philanthropists like William Gates, Sr., have made this city a unique catalyst for change. Seattle is a community small enough to encourage collegiality across scientific disciplines, and conversations across industries. No other city is a leader in areas as diverse as technology, retail, aerospace, and health care — and positioned precisely at the intersection of artificial intelligence, big data, and science.

The intellectual fervor of the tech revolution that Microsoft began here forty years ago pervades our culture. Entrepreneurship, innovation, and an inclination to expect the extraordinary are part of our DNA. They seed our urge to compete for the most advanced technologies, the most groundbreaking discoveries, and the best ways forward.

Deep Roots and Results

Founded in Seattle in 2006, the Institute has its roots in the groundbreaking work of Nobel Prize-winner Dr. E. Donnall Thomas at the University of Washington. His bone marrow transplants in cancer patients were the first use of stem cells in human medicine. The initial inspiration for the Institute underscores its public mission. In 2005, when Drs. Randall Moon, Charles Murry, and Tony Blau appeared before the Washington state legislature to advocate for stem cell research, the effort’s failure energized the trio. “So, we proposed this Institute… and the University agreed,” recollects Murry.

But that was just the beginning. In the past decade, ISCRM has been a leader in research grants, patented more than 250 discoveries with commercial potential, and started 20 companies. Fate Therapeutics (Nasdaq: FATE) and Universal Cells, Inc., are just two of the successful ventures born from ISCRM research.

State of the Art Facilities

The Institute is located at UW Medicine’s research complex in Seattle’s South Lake Union (SLU) medical/tech hub. With more than 50 labs and over 100,000 square feet of wet lab space, the Institute has become a West Coast locus of innovation and scientific discovery. ISCRM has four unique core resources, each with specialized equipment, staff expertise, training and/or services. Three of these cores were launched mostly with private funding, which is acknowledged through their naming. In addition to the research labs housed at SLU, there are around 70 labs on the UW main campus, and several dozen at partnering institutions around the city.